{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:30:44Z","timestamp":1793734244770,"version":"4.6.1"},"reference-count":140,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jns.2021.120020","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T16:23:48Z","timestamp":1633105428000},"page":"120020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Parkinsonism and ataxia"],"prefix":"10.1016","volume":"433","author":[{"given":"Giulia","family":"Franco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Di Fonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0005","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/mdc3.12042","article-title":"Movement disorders in autosomal dominant cerebellar ataxias: a systematic review","volume":"1","author":"Rossi","year":"2014","journal-title":"Mov Disord Clin Pract"},{"issue":"10","key":"10.1016\/j.jns.2021.120020_bb0010","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000035625.19871.DC","article-title":"SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings","volume":"59","author":"Furtado","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ana.10055","article-title":"Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism","volume":"50","author":"Shan","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archneur.61.1.35","article-title":"The parkinsonian phenotype of spinocerebellar ataxia type 2","volume":"61","author":"Lu","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120020_bb0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fneur.2017.00472","article-title":"Spinocerebellar ataxia type 2: Clinicogenetic aspects, mechanistic insights, and management approaches","volume":"8","author":"Velazquez-Perez","year":"2017","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/mds.21228","article-title":"Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients","volume":"22","author":"Modoni","year":"2007","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2007-971172","article-title":"Dominantly inherited ataxias: lessons learned from Machado-Joseph disease\/spinocerebellar ataxia type 3","volume":"27","author":"Paulson","year":"2007","journal-title":"Semin. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2021.120020_bb0040","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archneur.57.10.1495","article-title":"Extrapyramidal motor signs in degenerative ataxias","volume":"57","author":"Schols","year":"2000","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archneur.58.2.296","article-title":"Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family","volume":"58","author":"Gwinn-Hardy","year":"2001","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0050","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.parkreldis.2004.03.009","article-title":"The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family","volume":"10","author":"Lu","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0055","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.parkreldis.2006.04.009","article-title":"The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment","volume":"13","author":"Lin","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"issue":"16","key":"10.1016\/j.jns.2021.120020_bb0060","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e3181a18876","article-title":"Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism","volume":"72","author":"Kim","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120020_bb0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/B978-0-444-51892-7.00041-3","article-title":"Dentatorubral-pallidoluysian atrophy","volume":"103","author":"Tsuji","year":"2012","journal-title":"Handb. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2021.120020_bb0070","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/mds.20564","article-title":"Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6)","volume":"20","author":"Khan","year":"2005","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2021.120020_bb0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jnnp.2008.166728","article-title":"The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6","volume":"81","author":"Kim","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/brain\/aww269","article-title":"Clinical behaviour of spinocerebellar ataxia type 12 and intermediate length abnormal CAG repeats in PPP2R2B","volume":"140","author":"Srivastava","year":"2017","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.jns.2021.120020_bb0085","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/brain\/awh139","article-title":"Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20","volume":"127","author":"Knight","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.120020_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/bs.irn.2019.10.006","article-title":"Parkinsonism in Huntington\u2019s disease","volume":"149","author":"Reilmann","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00401235","article-title":"Juvenile Huntington disease","volume":"73","author":"van Dijk","year":"1986","journal-title":"Hum. Genet."},{"key":"10.1016\/j.jns.2021.120020_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.parkreldis.2019.06.025","article-title":"Juvenile parkinsonism: differential diagnosis, genetics, and treatment","volume":"67","author":"Niemann","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.120020_bb0105","doi-asserted-by":"crossref","first-page":"571843","DOI":"10.3389\/fneur.2020.571843","article-title":"Is Ataxia an underestimated symptom of Huntington\u2019s disease?","volume":"11","author":"Franklin","year":"2020","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0110","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1468-1331.2003.00601.x","article-title":"Highly disabling cerebellar presentation in Huntington disease","volume":"10","author":"Squitieri","year":"2003","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/jnnp.68.2.238","article-title":"Late onset levodopa responsive Huntington\u2019s disease with minimal chorea masquerading as Parkinson plus syndrome","volume":"68","author":"Reuter","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.jns.2021.120020_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11910-018-0890-y","article-title":"Novel imaging biomarkers for Huntington\u2019s disease and other hereditary Choreas","volume":"18","author":"Fazio","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"issue":"Pt 3","key":"10.1016\/j.jns.2021.120020_bb0130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/aws004","article-title":"Characterization of frontotemporal dementia and\/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72","volume":"135","author":"Boeve","year":"2012","journal-title":"Brain"},{"issue":"3\u20134","key":"10.1016\/j.jns.2021.120020_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/21678421.2015.1113298","article-title":"Pure cerebellar ataxia linked to large C9orf72 repeat expansion","volume":"17","author":"Corcia","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1399-0004.2012.01903.x","article-title":"Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease","volume":"83","author":"Lindquist","year":"2013","journal-title":"Clin. Genet."},{"key":"10.1016\/j.jns.2021.120020_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fnagi.2018.00045","article-title":"Atrophy in the thalamus but not cerebellum is specific for C9orf72 FTD and ALS patients - an atlas-based volumetric MRI study","volume":"10","author":"Schonecker","year":"2018","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.jns.2021.120020_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1054\/jocn.2001.0919","article-title":"Gerstmann-Straussler-Scheinker syndrome,fatal familial insomnia, and kuru: a review of these less common human transmissible spongiform encephalopathies","volume":"8","author":"Collins","year":"2001","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2021.120020_bb0155","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/B978-0-444-63945-5.00014-3","article-title":"Dominantly inherited prion protein cerebral amyloidoses - a modern view of Gerstmann-Straussler-Scheinker","volume":"153","author":"Ghetti","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0160","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000400","article-title":"Gerstmann-Straussler-Scheinker disease (PRNP p.D202N) presenting with atypical parkinsonism","volume":"6","author":"Baiardi","year":"2020","journal-title":"Neurol Genet"},{"issue":"Pt 9","key":"10.1016\/j.jns.2021.120020_bb0165","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/brain\/awn178","article-title":"Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature","volume":"131","author":"Pareyson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.120020_bb0170","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/B978-0-444-64076-5.00044-2","article-title":"Alexander disease","volume":"148","author":"Messing","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneurol.2008.555","article-title":"Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms","volume":"66","author":"Ibanez","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120020_bb0180","first-page":"546462","article-title":"Four copies of SNCA responsible for autosomal dominant Parkinson\u2019s disease in two Italian siblings","volume":"2015","author":"Ferese","year":"2015","journal-title":"Parkinsons Dis"},{"issue":"12","key":"10.1016\/j.jns.2021.120020_bb0185","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/mds.27527","article-title":"Genotype-phenotype relations for the Parkinson\u2019s disease genes SNCA, LRRK2, VPS35: MDSGene systematic review","volume":"33","author":"Trinh","year":"2018","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0190","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000358801","article-title":"The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies","volume":"42","author":"Ruano","year":"2014","journal-title":"Neuroepidemiology"},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","article-title":"Ataxia telangiectasia: a review","volume":"11","author":"Rothblum-Oviatt","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0032-1313915","article-title":"Neurodegeneration in ataxia telangiectasia: what is new? What is evident?","volume":"43","author":"Hoche","year":"2012","journal-title":"Neuropediatrics"},{"issue":"8","key":"10.1016\/j.jns.2021.120020_bb0205","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/mds.27319","article-title":"Ataxia-telangiectasia: a review of movement disorders, clinical features, and genotype correlations","volume":"33","author":"Levy","year":"2018","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0210","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/ana.25394","article-title":"Genotype, extrapyramidal features, and severity of variant ataxia-telangiectasia","volume":"85","author":"Schon","year":"2019","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0215","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archneur.59.4.527","article-title":"Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations","volume":"59","author":"Moghadasian","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2021.120020_bb0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.parkreldis.2018.07.006","article-title":"Movement disorders in cerebrotendinous xanthomatosis","volume":"58","author":"Stelten","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.120020_bb0225","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13023-014-0179-4","article-title":"Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management","volume":"9","author":"Nie","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0230","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-019-0372-4","article-title":"Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia","volume":"51","author":"Cortese","year":"2019","journal-title":"Nat. Genet."},{"issue":"Pt 10","key":"10.1016\/j.jns.2021.120020_bb0235","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/brain\/awu196","article-title":"Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia \u2018CANVAS\u2019 syndrome","volume":"137","author":"Wu","year":"2014","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0240","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/jnnp-2020-325092","article-title":"RFC1-related ataxia is a mimic of early multiple system atrophy","volume":"92","author":"Sullivan","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Pt 10","key":"10.1016\/j.jns.2021.120020_bb0245","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1093\/brain\/aws224","article-title":"Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort","volume":"135","author":"van Gassen","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jns.2021.120020_bb0250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2017.12.004","article-title":"SPG7 with parkinsonism responsive to levodopa and dopaminergic deficit","volume":"47","author":"Pedroso","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00415-009-0083-3","article-title":"SPG11 spastic paraplegia. A new cause of juvenile parkinsonism","volume":"256","author":"Anheim","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2021.120020_bb0260","series-title":"GeneReviews((R))","article-title":"Spastic Paraplegia 11","author":"Stevanin","year":"1993"},{"key":"10.1016\/j.jns.2021.120020_bb0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/B978-0-444-63233-3.00018-X","article-title":"Wilson disease and related copper disorders","volume":"147","author":"Lorincz","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2021.120020_bb0270","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/mds.21170","article-title":"Neurological manifestations in Wilson\u2019s disease: report of 119 cases","volume":"21","author":"Machado","year":"2006","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0275","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3174\/ajnr.A5936","article-title":"MR imaging of the brain in neurologic Wilson disease","volume":"40","author":"Yu","year":"2019","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2021.120020_bb0280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5334\/tohm.435","article-title":"Advances in Treatment of Wilson Disease","volume":"8","author":"Aggarwal","year":"2018","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0285","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jnnp.59.3.318","article-title":"Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome","volume":"59","author":"Nielsen","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0290","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1531-8257(200011)15:6<1204::AID-MDS1021>3.0.CO;2-T","article-title":"Clinical report of three patients with hereditary hemochromatosis and movement disorders","volume":"15","author":"Demarquay","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120020_bb0295","first-page":"18(2)","article-title":"A review of gaucher disease pathophysiology, clinical presentation and treatments","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.jns.2021.120020_bb0300","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.120020_bb0305","first-page":"8(4)","article-title":"GBA, Gaucher disease, and Parkinson's disease: from genetic to clinic to new therapeutic approaches","author":"Riboldi","year":"2019","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.jns.2021.120020_bb0310","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/mdc3.13031","article-title":"Parkinsonism in patients with Neuronopathic (type 3) Gaucher disease: a case series","volume":"7","author":"Ryan","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.jns.2021.120020_bb0315","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcmd.2016.10.011","article-title":"Novel hyperkinetic dystonia-like manifestation and neurological disease course of Swedish Gaucher patients","volume":"68","author":"Machaczka","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.jns.2021.120020_bb0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-5-16","article-title":"Niemann-pick disease type C","volume":"5","author":"Vanier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"Pt 1","key":"10.1016\/j.jns.2021.120020_bb0325","first-page":"120","article-title":"The adult form of Niemann-pick disease type C","volume":"130","author":"Sevin","year":"2007","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.jns.2021.120020_bb0330","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s11910-013-0366-z","article-title":"Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum","volume":"13","author":"Cotman","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"10.1016\/j.jns.2021.120020_bb0335","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1212\/01.wnl.0000252825.85947.2f","article-title":"Adult neuronal ceroid lipofuscinosis caused by deficiency in palmitoyl protein thioesterase 1","volume":"68","author":"Ramadan","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jns.2021.120020_bb0340","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.410420517","article-title":"Clinical and magnetic resonance imaging findings in batten disease: analysis of the major mutation (1.02-kb deletion)","volume":"42","author":"Jarvela","year":"1997","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0345","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.57.1.127","article-title":"Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X","volume":"57","author":"Hagerman","year":"2001","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2021.120020_bb0350","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome - features, mechanisms and management","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0355","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1086\/374321","article-title":"Fragile X premutation tremor\/ataxia syndrome: molecular, clinical, and neuroimaging correlates","volume":"72","author":"Jacquemont","year":"2003","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0360","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.parkreldis.2014.01.006","article-title":"Parkinsonism in fragile X-associated tremor\/ataxia syndrome (FXTAS): revisited","volume":"20","author":"Niu","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Pt 8","key":"10.1016\/j.jns.2021.120020_bb0365","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/brain\/awh535","article-title":"The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group","volume":"128","author":"Kamm","year":"2005","journal-title":"Brain"},{"issue":"18","key":"10.1016\/j.jns.2021.120020_bb0370","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1212\/WNL.0b013e318271f7ff","article-title":"FXTAS: new insights and the need for revised diagnostic criteria","volume":"79","author":"Apartis","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2021.120020_bb0375","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/ng1826","article-title":"PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron","volume":"38","author":"Morgan","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jns.2021.120020_bb0380","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3389\/fneur.2018.01100","article-title":"PLA2G6-associated neurodegeneration (PLAN): review of clinical phenotypes and genotypes","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0385","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mdc3.12319","article-title":"Early Ataxia and subsequent parkinsonism: PLA2G6 mutations cause a continuum rather than three discrete phenotypes","volume":"4","author":"Erro","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.jns.2021.120020_bb0390","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2016.12.010","article-title":"New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients","volume":"36","author":"Vroegindeweij","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.120020_bb0395","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fnins.2019.00325","article-title":"Aceruloplasminemia: a severe neurodegenerative disorder deserving an early diagnosis","volume":"13","author":"Marchi","year":"2019","journal-title":"Front. Neurosci."},{"issue":"19","key":"10.1016\/j.jns.2021.120020_bb0400","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease","volume":"68","author":"Di Fonzo","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0405","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.26243","article-title":"The role of ATP13A2 in Parkinson\u2019s disease: clinical phenotypes and molecular mechanisms","volume":"30","author":"Park","year":"2015","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0410","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5114\/fn.2019.88459","article-title":"Clinical and ultrastructural findings in an ataxic variant of Kufor-Rakeb syndrome","volume":"57","author":"Pietrzak","year":"2019","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.jns.2021.120020_bb0415","doi-asserted-by":"crossref","first-page":"355","DOI":"10.5334\/tohm.317","article-title":"Neuroferritinopathy: pathophysiology, presentation, differential diagnoses and management","volume":"6","author":"Kumar","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"18","key":"10.1016\/j.jns.2021.120020_bb0420","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1212\/01.wnl.0000310985.40011.d6","article-title":"T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation","volume":"70","author":"McNeill","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120020_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.12.024","article-title":"Deconstructing Fahr\u2019s disease\/syndrome of brain calcification in the era of new genes","volume":"37","author":"Batla","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"issue":"10","key":"10.1016\/j.jns.2021.120020_bb0430","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11910-019-0986-z","article-title":"MYORG mutations: a major cause of recessive primary familial brain calcification","volume":"19","author":"Bauer","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0435","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuron.2018.05.037","article-title":"Biallelic mutations in MYORG cause autosomal recessive primary familial brain calcification","volume":"98","author":"Yao","year":"2018","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0440","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/brain\/awz095","article-title":"Biallelic MYORG mutation carriers exhibit primary brain calcification with a distinct phenotype","volume":"142","author":"Grangeon","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0445","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000250334.48038.7a","article-title":"Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys","volume":"68","author":"Horvath","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0450","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/1531-8249(199901)45:1<130::AID-ART21>3.0.CO;2-Z","article-title":"A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism\/MELAS overlap syndrome","volume":"45","author":"De Coo","year":"1999","journal-title":"Ann. Neurol."},{"issue":"8\u20139","key":"10.1016\/j.jns.2021.120020_bb0455","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neurol.2015.03.011","article-title":"Parkinsonism in a patient with Leber hereditary optic neuropathy (LHON)","volume":"171","author":"Vital","year":"2015","journal-title":"Rev. Neurol. (Paris)"},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0460","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2013.01.012","article-title":"Juvenile parkinsonism, hypogonadism and Leigh-like MRI changes in a patient with m.4296G>a mutation in mitochondrial DNA","volume":"13","author":"Martikainen","year":"2013","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0465","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41582-018-0101-0","article-title":"POLG-related disorders and their neurological manifestations","volume":"15","author":"Rahman","year":"2019","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0470","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/jamaneurol.2016.0355","article-title":"Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease","volume":"73","author":"Martikainen","year":"2016","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.jns.2021.120020_bb0475","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ana.20831","article-title":"Early-onset familial parkinsonism due to POLG mutations","volume":"59","author":"Davidzon","year":"2006","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0480","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/mds.22865","article-title":"Sustained dopaminergic response of parkinsonism and depression in POLG-associated parkinsonism","volume":"25","author":"Synofzik","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0485","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1971400915621324","article-title":"Characteristic brain MRI findings in ataxia-neuropathy spectrum related to POLG mutation","volume":"29","author":"Henao","year":"2016","journal-title":"Neuroradiol. J."},{"issue":"7","key":"10.1016\/j.jns.2021.120020_bb0490","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archneur.64.7.998","article-title":"Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle","volume":"64","author":"Baloh","year":"2007","journal-title":"Arch. Neurol."},{"issue":"14","key":"10.1016\/j.jns.2021.120020_bb0495","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/WNL.0000000000010674","article-title":"Twinkle-associated familial parkinsonism with Lewy pathology: cause or predisposition?","volume":"95","author":"Breen","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ana.24835","article-title":"Leigh map: a novel computational diagnostic resource for mitochondrial disease","volume":"81","author":"Rahman","year":"2017","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0505","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.24551","article-title":"Leigh syndrome: one disorder, more than 75 monogenic causes","volume":"79","author":"Lake","year":"2016","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0510","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2021.120020_bb0515","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.irn.2019.10.004","article-title":"Multiple system atrophy","volume":"149","author":"Fanciulli","year":"2019","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jns.2021.120020_bb0520","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2016.11.010","article-title":"Sniffing the diagnosis: olfactory testing in neurodegenerative parkinsonism","volume":"35","author":"Krismer","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0525","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/mdc3.12404","article-title":"Role of magnetic resonance imaging in the diagnosis of multiple system atrophy","volume":"4","author":"Kim","year":"2017","journal-title":"Mov Disord Clin Pract"},{"issue":"9","key":"10.1016\/j.jns.2021.120020_bb0530","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/mds.22583","article-title":"Cerebellar involvement in progressive supranuclear palsy: a clinicopathological study","volume":"24","author":"Kanazawa","year":"2009","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0535","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14802\/jmd.19061","article-title":"Progressive Supranuclear palsy with predominant cerebellar Ataxia","volume":"13","author":"Ando","year":"2020","journal-title":"J Mov Disord"},{"issue":"6 Neuroinfectious Disease","key":"10.1016\/j.jns.2021.120020_bb0540","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1212\/CON.0000000000000251","article-title":"Prion diseases","volume":"21","author":"Geschwind","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jns.2021.120020_bb0545","first-page":"9","article-title":"Movement disorders in prionopathies: a systematic review","author":"Rodriguez-Porcel","year":"2019","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0550","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14802\/jmd.16008","article-title":"Movement disorders following cerebrovascular lesions: etiology, treatment options and prognosis","volume":"9","author":"Kwon","year":"2016","journal-title":"J Mov Disord"},{"issue":"8","key":"10.1016\/j.jns.2021.120020_bb0555","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1093\/brain\/awy161","article-title":"Localizing parkinsonism based on focal brain lesions","volume":"141","author":"Joutsa","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0560","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/archneur.62.4.618","article-title":"Cerebellar ataxia and central nervous system whipple disease","volume":"62","author":"Matthews","year":"2005","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0565","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/mds.24950","article-title":"Acquired neurosyphilis presenting as movement disorders","volume":"27","author":"Shah","year":"2012","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.jns.2021.120020_bb0570","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/00023210-200216100-00002","article-title":"HIV-related movement disorders: epidemiology, pathogenesis and management","volume":"16","author":"Cardoso","year":"2002","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0575","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1531-8257(200005)15:3<561::AID-MDS1021>3.0.CO;2-K","article-title":"Movement disorders in 30 patients with tuberculous meningitis","volume":"15","author":"Alarcon","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2021.120020_bb0580","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.parkreldis.2018.06.008","article-title":"Movement disorders in non-encephalopathic Hashimoto\u2019s thyroiditis","volume":"55","author":"Miranda","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2021.120020_bb0585","first-page":"10(8)","article-title":"Movement disorders related to gluten sensitivity: a systematic review","author":"Vinagre-Aragon","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jns.2021.120020_bb0590","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11910-017-0709-2","article-title":"Autoimmune movement disorders: a clinical and laboratory approach","volume":"17","author":"Honorat","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"Pt 8","key":"10.1016\/j.jns.2021.120020_bb0595","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jns.2021.120020_bb0600","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mds.21314","article-title":"Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes","volume":"22","author":"Matsumoto","year":"2007","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0605","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/sleep\/30.6.767","article-title":"REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis","volume":"30","author":"Compta","year":"2007","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0610","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity","volume":"49","author":"Yu","year":"2001","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2021.120020_bb0615","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/jnnp-2015-311569","article-title":"Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia","volume":"87","author":"Tada","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0620","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/mdc3.12370","article-title":"Paraneoplastic atypical parkinsonism with anti-CRMP5 antibodies and severe caudate and Putaminal Hypometabolism on 18-Fluorodeoxyglucose positron emission tomography of the brain","volume":"4","author":"Yap","year":"2017","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"10.1016\/j.jns.2021.120020_bb0625","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","article-title":"Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases","volume":"90","author":"Dubey","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120020_bb0630","first-page":"7(3)","article-title":"Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies","author":"Simard","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jns.2021.120020_bib692","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jns.2021.120020_bib691","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.4065\/81.9.1207","article-title":"Glutamic Acid Decarboxylase Autoimmunity With Brainstem, Extrapyramidal, and Spinal Cord Dysfunction","volume":"81","author":"Pittock","year":"2006","journal-title":"Mayo Clinic Proceedings."},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0635","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10072-020-04685-y","article-title":"Subacute axial parkinsonism associated with anti-Ri antibodies","volume":"42","author":"Di Schino","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2021.120020_bb0640","doi-asserted-by":"crossref","first-page":"577345","DOI":"10.1016\/j.jneuroim.2020.577345","article-title":"Anti- RI antibody associated progressive supranuclear palsy like presentation in a patient with breast carcinoma","volume":"347","author":"Takkar","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jns.2021.120020_bb0645","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","article-title":"Systematic review of the clinical spectrum of CASPR2 antibody syndrome","volume":"267","author":"Boyko","year":"2020","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0650","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10072-017-3222-0","article-title":"Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia","volume":"39","author":"Kannoth","year":"2018","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2021.120020_bb0655","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2021.120020_bb0660","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2016.01.006","article-title":"Autoimmune atypical parkinsonism - a group of treatable parkinsonism","volume":"362","author":"Kannoth","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2021.120020_bb0665","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.parkreldis.2015.08.014","article-title":"Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis","volume":"21","author":"Kurtis","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2021.120020_bb0670","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2021.120020_bb0675","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/WCO.0000000000000677","article-title":"Neurological profiles beyond the sleep disorder in patients with anti-IgLON5 disease","volume":"32","author":"Gaig","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"18","key":"10.1016\/j.jns.2021.120020_bb0680","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","article-title":"Clinical manifestations of the anti-IgLON5 disease","volume":"88","author":"Gaig","year":"2017","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.jns.2021.120020_bb0685","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","article-title":"DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients","volume":"83","author":"Tobin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2021.120020_bb0690","series-title":"Normal Pressure Hydrocephalus, in StatPearls","author":"Di","year":"2021"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21027167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X21027167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:58:33Z","timestamp":1758383913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X21027167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":140,"alternative-id":["S0022510X21027167"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2021.120020","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinsonism and ataxia","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2021.120020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120020"}}